IP Library › Granted Patent US 10,813,896
Granted Patent B2
US 10,813,896 · App. 16/676,014 · Granted Oct 27, 2020

Treatment of intrahepatic cholestatic diseases

Inventors: Pol Boudes (Fremont, CA); Charles A. McWherter (Oakland, CA)
Assignee: CymaBay Therapeutics, Inc.
A61K31/192A61K9/0053A61K9/4858A61P1/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,813,896
App. No.
16/676,014
Granted
Oct 27, 2020
Kind
B2
Abstract

Treatment of intrahepatic cholestatic diseases by therapy with seladelpar or a salt thereof.

Claims (10)

1. A method of treating primary sclerosing cholangitis by administering a therapeutically effective amount of a compound that is seladelpar or a salt thereof, where the amount of the compound is between 0.5 mg/day and 2 mg/day when the amount of the compound is calculated as seladelpar.

2. The method of claim 1 where the compound is administered orally.

3. The method of claim 1 where the amount of the compound is 0.5 mg/day, 1 mg/day, or 2 mg/day.

4. The method of claim 3 where the amount of the compound is 0.5 mg/day.

5. The method of claim 3 where the amount of the compound is 1 mg/day.

6. The method of claim 3 where the amount of the compound is 2 mg/day.

7. The method of claim 1 where the compound is administered once/day.

8. The method of claim 1 where the compound is administered between once/week and every other day.

9. The method of claim 1 where the compound is a seladelpar L-lysine salt.

10. The method of claim 9 where the compound is seladelpar L-lysine dihydrate salt.

Assignments (1)
RELEASE OF SECURITY INTEREST Recorded Oct 3, 2024
From: ABW CYCLOPS SPV LP
To: CYMABAY THERAPEUTICS, INC.
Reel/Frame 069833/0155 →